P. Seo

P. Merkel, L. Moreland, L. Zgaga, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Vasculitis: lessons learned.

P. Seo, 2009, Current opinion in rheumatology.

Persistent or New Onset Microscopic Hematuria in Patients with Small Vessel Vasculitis in Remission: Findings on Renal Biopsy

P. Seo, D. Geetha, M. Kuperman, 2012, The Journal of Rheumatology.

Eosinophilic Granulomatosis with Polyangiitis: Challenges and Opportunities.

P. Seo, 2016, The journal of allergy and clinical immunology. In practice.

Serum Biomarkers in Patients with Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)

P. Merkel, J. Zwerina, P. Monach, 2015, PloS one.

Pregnancy and vasculitis.

P. Seo, 2007, Rheumatic diseases clinics of North America.

Self-Reported Data and Physician-Reported Data in Patients With Eosinophilic Granulomatosis With Polyangiitis: Comparative Analysis

P. Merkel, L. Moreland, P. Monach, 2022, Interactive journal of medical research.

Clinical Manifestations and Long‐Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America

P. Merkel, L. Moreland, S. Chung, 2021, ACR open rheumatology.

Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.

P. Merkel, K. Maksimowicz-McKinnon, P. Monach, 2015, Rheumatology.

Small-vessel and medium-vessel vasculitis.

J. Stone, P. Seo, 2007, Arthritis and rheumatism.

Advances in Therapy for ANCA-Associated Vasculitis

P. Seo, D. Geetha, 2012, Current Rheumatology Reports.

Rituximab for the Treatment of Relapses in ANCA-associated Vasculitis

P. Merkel, J. Stone, L. Viviano, 2014 .

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, L. Viviano, 2014, Arthritis & rheumatology.

Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2019, Arthritis & rheumatology.

ANCA-Associated Vasculitis Pathogenesis: A Commentary

P. Seo, B. Antiochos, E. Gapud, 2017, Current Rheumatology Reports.

Outcomes of Nonsevere Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated With Glucocorticoids

P. Merkel, J. Stone, C. Kallenberg, 2015, Arthritis & rheumatology.

Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2019, Arthritis & rheumatology.

Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

D. Schroeder, P. Merkel, J. Stone, 2018 .

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

D. Schroeder, P. Merkel, J. Stone, 2018, Arthritis & rheumatology.

Myeloperoxidase–Antineutrophil Cytoplasmic Antibody (ANCA)–Positive and ANCA‐Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets

P. Merkel, J. Stone, C. Kallenberg, 2016, Arthritis & rheumatology.

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2013, Arthritis and rheumatism.

Sequence‐Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2

P. Merkel, E. Remmers, D. Kastner, 2020, Arthritis & rheumatology.

Activation of a Latent Epitope Causing Differential Binding of Anti-Neutrophil Cytoplasmic Antibodies to Proteinase 3

P. Merkel, J. Stone, C. Kallenberg, 2019, bioRxiv.

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis

D. Schroeder, P. Merkel, J. Stone, 2018, Rheumatology.

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis

P. Merkel, J. Stone, E. S. St. Clair, 2017, Clinical and experimental immunology.

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index

P. Merkel, V. Tesar, A. Vaglio, 2010, Annals of the rheumatic diseases.

Large-vessel vasculitis.

J. Stone, P. Seo, 2004, Arthritis and rheumatism.

Pauci-immune Glomerulonephritis in Systemic Lupus Erythematosus (SLE)

M. Petri, D. Fine, P. Seo, 2018, Cureus.

Cases from the Osler Medical Service at Johns Hopkins University. Pseudoachalasia due to esophageal adenocarcinoma.

P. Seo, 2002, The American journal of medicine.

Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2021, ACR open rheumatology.

Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis

P. Merkel, T. Mustelin, L. Moreland, 2022, Arthritis Research & Therapy.

SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

P. Seo, D. Geetha, Lauren Floyd, 2021, Kidney International Reports.

SARS-CoV-2 vaccine response in ANCA associated vasculitis patients

P. Seo, D. Geetha, Lauren Floyd, 2021, Kidney International Reports.

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multicenter Experience

U. Specks, P. Seo, F. Fervenza, 2011, Transplantation.

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension

S. Mathai, P. Seo, R. Manno, 2018, Cureus.

Successful Induction of Remission With Rituximab for Relapse of ANCA‐Associated Vasculitis Post‐Kidney Transplant: Report of Two Cases

U. Specks, P. Seo, D. Geetha, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Inflammatory Diseases of the Aorta: JACC Focus Seminar, Part 2.

Z. Fayad, P. Robson, J. Olin, 2022, Journal of the American College of Cardiology.

Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

L. Trupin, M. Konig, A. Agarwal, 2021, The Lancet Rheumatology.

Clinical for Inflammatory Syndrome in Children Associated With and in

L. Henderson, A. Tremoulet, D. Karp, 2020 .

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2019, Arthritis & rheumatology.

Telemedicine in Adult Rheumatology: In Practice and in Training

M. Bolster, A. Dua, P. Seo, 2021, Arthritis care & research.

Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission

P. Merkel, J. Stone, E. S. St. Clair, 2022, Annals of the Rheumatic Diseases.

IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

P. Merkel, L. Moreland, P. Monach, 2017, Clinical and experimental rheumatology.

Wegener's granulomatosis: managing more than inflammation

P. Seo, 2008, Current opinion in rheumatology.

The future of damage assessment in vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2007, The Journal of rheumatology.

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.

J. Krischer, D. Felson, P. Merkel, 2005, The Journal of rheumatology.

An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)

J. Krischer, P. Merkel, P. Monach, 2013, Annals of the rheumatic diseases.

Development of comprehensive disease assessment in systemic vasculitis.

P. Bacon, K. De Groot, R. Luqmani, 2007, Annals of the rheumatic diseases.

Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use.

Amit R. Patel, S. Gabriel, E. Nagel, 2016, International journal of cardiology.

Renal Transplantation in the ANCA‐Associated Vasculitides

P. Seo, D. Geetha, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome‐Wide Association Study

P. Merkel, J. Wren, T. Vyse, 2015, Arthritis & rheumatology.

Otolaryngological Progression of Granulomatosis with Polyangiitis after Systemic Treatment with Rituximab

P. Seo, David J Mener, Jean Kim, 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Association of a nonsynonymous single-nucleotide polymorphism of matrix metalloproteinase 9 with giant cell arteritis.

T. Beaty, R. Eagle, P. Savino, 2008, Arthritis and rheumatism.

Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

P. Merkel, J. Stone, Hyon K. Choi, 2015, Annals of the rheumatic diseases.

Patient‐reported outcome assessment in vasculitis may provide important data and a unique perspective

P. Merkel, P. Seo, K. Herlyn, 2010, Arthritis care & research.

Advances in the use of biologic agents for the treatment of systemic vasculitis

S. Chung, P. Seo, Sharon A. Chung, 2009, Current opinion in rheumatology.

BK Virus Replication in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

S. Ghazarian, P. Seo, D. Geetha, 2013, American Journal of Nephrology.

Cardiac Involvement in Granulomatosis with Polyangiitis

P. Merkel, L. Moreland, P. Monach, 2015, The Journal of Rheumatology.

Life-Threatening Presentations of ANCA-Associated Vasculitis

P. Seo, D. Geetha, 2011 .

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2010, The New England journal of medicine.

Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.

U. Specks, K. Keogh, P. Seo, 2008, The Journal of rheumatology.

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2

L. Henderson, D. Karp, A. Tremoulet, 2020, Arthritis & rheumatology.

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.

J. Krischer, P. Merkel, J. Stone, 2011, Arthritis and rheumatism.

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

P. Merkel, J. Stone, John C. Davis, 2011, Arthritis care & research.

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis.

P. Merkel, L. Moreland, Marcus Y. Chen, 2019, Rheumatology.

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

D. Schroeder, P. Merkel, J. Stone, 2016, Arthritis & rheumatology.

Rituximab for treatment of severe renal disease in ANCA associated vasculitis

T. Cavero, V. Tesar, D. Jayne, 2016, Journal of Nephrology.

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

P. Gregersen, C. Wijmenga, J. Barrett, 2015, American journal of human genetics.

Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis

P. Merkel, K. Maksimowicz-McKinnon, P. Monach, 2013, Journal of Rheumatology.

Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis

J. Krischer, P. Merkel, J. Stone, 2011, Annals of the rheumatic diseases.

Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study

P. Seo, 2010 .

Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes

P. Seo, D. Geetha, R. Manno, 2019, Clinical Rheumatology.

Factors Affecting Dilation Interval in Patients With Granulomatosis With Polyangiitis-Associated Subglottic and Glottic Stenosis

Ioan A. Lina, A. Hillel, P. Seo, 2021, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis

P. Merkel, J. Stone, C. Kallenberg, 2020, JCI insight.

Identification of multiple genetic susceptibility loci in Takayasu arteritis.

P. Merkel, J. Guthridge, O. Karadag, 2013, American journal of human genetics.

P. Merkel, J. Stone, C. Kallenberg, 2015, Arthritis & rheumatology.

Peripheral CD5+ B Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2015, Arthritis & rheumatology.

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3

L. Henderson, D. Karp, A. Tremoulet, 2022, Arthritis & rheumatology.

ANCA Vasculitis Induction Management During the COVID-19 Pandemic

V. Tesar, V. Derebail, A. Kronbichler, 2021, Kidney International Reports.

Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis.

K. Siminovitch, P. Merkel, J. Stone, 2012, Arthritis and rheumatism.

Rheumatology Fellowship Recruitment in 2020: Benefits, Challenges, and Adaptations

M. Bolster, A. Dua, P. Seo, 2020, Arthritis care & research.

The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.

Stephan Ripke, Delnaz Roshandel, Soumya Raychaudhuri, 2013, Arthritis and rheumatism.

Development of comprehensive disease assessment in systemic vasculitis

P. Bacon, R. Luqmani, D. Jayne, 2007 .

Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study

A. Le, P. Seo, D. Geetha, 2021, Journal of Nephrology.

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis

P. Merkel, K. Maksimowicz-McKinnon, P. Monach, 2012, Annals of the rheumatic diseases.

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis

A. Azar, P. Seo, D. Geetha, 2019, Cureus.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.

P. Merkel, J. Stone, C. Kallenberg, 2015, Journal of the American Society of Nephrology : JASN.

Extended Follow-up of Treatment with Rituximab Versus Cyclophosphamide for Remission-Induction of ANCA-Associated Vasculitis : Which Subsets Are At Greatest Risk for Flare?

P. Merkel, J. Stone, C. Kallenberg, 2011 .

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

P. Merkel, Javier Martín, M. González-Gay, 2017, Scientific Reports.

Cases from the medical grand rounds of the Osler Medical Service at Johns Hopkins University.

P. Seo, 2002, American Journal of Medicine.

Renal Transplant in Wegener’s Granulomatosis Compared to Microscopic Polyangiitis

H. Rabb, M. Haas, E. Kraus, 2010, The Journal of Rheumatology.

Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9

P. Merkel, M. Boers, T. Neogi, 2009, The Journal of Rheumatology.

Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

M. Konig, P. Merkel, J. Stone, 2022, Arthritis & rheumatology.

Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.

Yichun Hu, P. Seo, D. Geetha, 2014, Seminars in arthritis and rheumatism.

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

D. Schroeder, P. Merkel, J. Stone, 2019, Journal of autoimmunity.

Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Seo, D. Geetha, G. Raman, 2020, Kidney International Reports.

Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis

P. Merkel, J. Stone, C. Kallenberg, 2017, American Journal of Nephrology.

Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis

P. Seo, D. Geetha, R. Manno, 2019, American Journal of Nephrology.

Assessment of damage in vasculitis: expert ratings of damage.

P. Merkel, R. Luqmani, D. Jayne, 2009, Rheumatology.

Efficacy of leflunomide in the treatment of vasculitis.

P. Merkel, L. Moreland, L. Barra, 2020, Clinical and experimental rheumatology.

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1

L. Henderson, D. Karp, A. Tremoulet, 2020, Arthritis & rheumatology.

Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al

A. Azar, P. Seo, D. Geetha, 2021, Annals of the Rheumatic Diseases.

Assessment of health‐related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)

P. Merkel, J. Stone, M. Boers, 2012, Arthritis care & research.

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

E. Matteson, F. Buttgereit, J. Smolen, 2023, Annals of the rheumatic diseases.

The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis

P. Merkel, M. Boers, G. Tómasson, 2011, The Journal of Rheumatology.

Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2017, Arthritis care & research.

Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis.

P. Merkel, L. Moreland, P. Monach, 2023, Clinical immunology.

The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

B. Rovin, P. Merkel, J. Stone, 2016, Arthritis & rheumatology.

Activation of a Latent Epitope Causing Differential Binding of Anti-Neutrophil Cytoplasmic Antibodies to Proteinase 3

P. Merkel, J. Stone, C. Kallenberg, 2022, bioRxiv.

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis

D. Schroeder, P. Merkel, J. Stone, 2020, Frontiers in Immunology.

Alpha₁-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis.

P. Merkel, J. Stone, J. Edberg, 2010, Arthritis and rheumatism.

Development of Outcome Measures for Large-vessel Vasculitis for Use in Clinical Trials: Opportunities, Challenges, and Research Agenda

P. Merkel, M. Boers, E. Matteson, 2011, Journal of Rheumatology.

Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy

P. Seo, D. Geetha, R. Manno, 2018, Cureus.

SAT0012 DETECTION OF CIRCULATING PR3-SPECIFIC B CELLS IN PATIENTS WITH ACTIVE ANCA-ASSOCIATED VASCULITIS

P. Merkel, J. Stone, J. Pers, 2019, SATURDAY, 15 JUNE 2019.

Virtually Speaking: The Impact of a Nationwide Synchronous and Asynchronous Learning Forum

L. Gensler, M. Bolster, A. Dua, 2022, Arthritis care & research.

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course

A. Azar, P. Seo, D. Geetha, 2022, European journal of rheumatology.

Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2021, JCI insight.

Vitamin D status in ANCA-associated vasculitis

P. Merkel, L. Moreland, P. Monach, 2023, Rheumatology advances in practice.

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis

P. Merkel, J. Stone, L. Leng, 2018, Arthritis & rheumatology.

Ocular manifestations of ANCA-associated vasculitis.

P. Merkel, L. Moreland, P. Monach, 2022, Rheumatology.

083. COMPARISON OF ARTERIAL PATTERNS OF DISEASE IN TAKAYASU’S ARTERITIS AND GIANT CELL ARTERITIS

P. Merkel, L. Moreland, K. Maksimowicz-McKinnon, 2019, Rheumatology.

Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

P. Merkel, Javier Martín, M. González-Gay, 2017, Scientific Reports.

053. CLINICAL UTILITY OF SERIAL MEASUREMENTS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES TARGETING PROTEINASE 3 IN ANCA-ASSOCIATED VASCULITIS

D. Schroeder, P. Merkel, J. Stone, 2019, Rheumatology.

L. Henderson, A. Tremoulet, D. Karp, 2021 .

Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism

P. Merkel, C. Kallenberg, M. Prunotto, 2023, RMD Open.

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome‐Wide Association Study

P. Merkel, J. Wren, T. Vyse, 2015 .

Large-vessel vasculitis.

J. Stone, P. Seo, 2004, Arthritis and rheumatism.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Current Status of Outcome Measure Development in Vasculitis

P. Merkel, M. Boers, E. Matteson, 2014, The Journal of Rheumatology.

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome‐Wide Association Study

J. Wren, T. Vyse, A. Adler, 2015, Arthritis & rheumatology.

Development of comprehensive disease assessment in systemic vasculitis

P. Bacon, R. Luqmani, D. Jayne, 2006, Postgraduate Medical Journal.

Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis.

K. Siminovitch, S. Raychaudhuri, C. Amos, 2013, Arthritis and rheumatism.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

C. Kallenberg, L. Viviano, B. Fessler, 2013, The New England journal of medicine.

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis

Hyon K. Choi, K. Liao, P. Monach, 2020 .

The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA‐Associated Vasculitis

L. Moreland, P. Monach, M. Wechsler, 2023, Arthritis & rheumatology.

Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9

M. Boers, T. Neogi, R. Luqmani, 2009, The Journal of Rheumatology.

MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis.

F. Martínez-Murillo, R. Eagle, P. Savino, 2009, Rheumatology.

Damage in ANCA-associated vasculitis: Preliminary evidence for the ANCA-associated vasculitis index of damage (AVID).

J. Stone, C. Kallenberg, E. Clair, 2006 .

Urine and Plasma Complement Ba Levels During Disease Flares in Patients With Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

H. Nagaraja, B. Rovin, L. Moreland, 2023, Kidney international reports.